BlackRock Institutional Trust’s Collegium Pharmaceutical COLL Stock Holding History

BlackRock Institutional Trust’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$6.42M	Buy	412,376 +151,044	+58%	+$2.51M	﹤0.01%	2630
2016 Q3	$5.03M	Hold	261,332	–	–	﹤0.01%	2685
2016 Q2	$3.1M	Buy	261,332 +75,984	+41%	+$1.26M	﹤0.01%	2872
2016 Q1	$3.36M	Buy	185,348 +45,120	+32%	+$820K	﹤0.01%	2835
2015 Q4	$3.86M	Buy	140,228 +1,747	+1%	+$36.8K	﹤0.01%	2842
2015 Q3	$3.06M	Buy	138,481 +97,213	+236%	+$1.76M	﹤0.01%	2937
2015 Q2	$637K	Buy	+41,268	New	+$714K	﹤0.01%	3460

Other funds holding COLL

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock Institutional Trust's COLL Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Collegium Pharmaceutical (COLL) stake by 58% in Q4 2016, buying an estimated $2.51M and bringing the position to 412,376 shares worth $6.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2630.

BlackRock Institutional Trust first reported a position in COLL in Q2 2015 and has held it in 7 quarters since. 88 funds tracked by Wall St. Rank hold COLL as of Q4 2016.

BlackRock Institutional Trust held 412,376 shares of Collegium Pharmaceutical worth $6.42M as of Q4 2016.
BlackRock Institutional Trust bought 151,044 Collegium Pharmaceutical shares in Q4 2016, an estimated $2.51M.
Collegium Pharmaceutical made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2630 holding.
BlackRock Institutional Trust first reported a position in Collegium Pharmaceutical in Q2 2015 and has held it in 7 quarters since.
88 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.